Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Noble Romans (NROM) Research & Development (2016 - 2018)

Noble Romans has reported Research & Development over the past 8 years, most recently at $26368.0 for Q4 2018.

  • Quarterly results put Research & Development at $26368.0 for Q4 2018, up 5.64% from a year ago — trailing twelve months through Dec 2018 was $102883.0 (down 39.83% YoY), and the annual figure for FY2018 was $102883.0, down 39.83%.
  • Research & Development for Q4 2018 was $26368.0 at Noble Romans, up from $23945.0 in the prior quarter.
  • Over the last five years, Research & Development for NROM hit a ceiling of $83427.0 in Q4 2015 and a floor of $21939.0 in Q1 2018.
  • Median Research & Development over the past 4 years was $48134.0 (2017), compared with a mean of $46862.1.
  • Peak annual rise in Research & Development hit 39.9% in 2017, while the deepest fall reached 67.75% in 2017.
  • Noble Romans' Research & Development stood at $83427.0 in 2015, then dropped by 7.22% to $77407.0 in 2016, then crashed by 67.75% to $24961.0 in 2017, then grew by 5.64% to $26368.0 in 2018.
  • The last three reported values for Research & Development were $26368.0 (Q4 2018), $23945.0 (Q3 2018), and $30631.0 (Q2 2018) per Business Quant data.